Are you looking for a little exposure to the small side of the market? If you are, you might want to add the small cap ASX shares listed below to your watchlists.
I think all three have the potential to be stars of the future. Here’s why I like them:
Alcidion Group Ltd (ASX: ALC)
Alcidion is a $150 million healthcare informatics solutions company. It provides software which has been designed to improve the efficacy and cost of delivering services to patients and reduce hospital-acquired complications. The company has a number of software solutions being used by healthcare institutions across the ANZ and UK. These include the Patientrack patient safety and communications system and the Miya Precision health analytics platform.
Clover Corporation Limited (ASX: CLV)
Clover is a $375 million specialist ingredients producer. It produces ingredients such as the highly sought-after omega-3 oils that go into infant formula, supplements, and baby food products. Clover has been growing at a strong rate over the last few years thanks largely to the increasing demand for ingredients from infant formula market. The good news is that this strong growth looks likely to continue over the coming years thanks to favourable changes to ingredient requirements in a number of key markets. This could make Clover a small cap to watch.
Mach7 Technologies Ltd (ASX: M7T)
Mach7 is a $230 million medical imaging data management solutions provider. It provides an Enterprise Imaging Platform that unlocks disparate archive silos, consolidates patient data, and simplifies sharing and access. This allows users to improve patient care, reach compliance goals, and deliver clinical and operational decision support enterprise wide. The company has also recently announced the acquisition of Client Outlook. Not only has the acquisition of the leading provider of enterprise image viewing technology bolstered its offering, it has lifted its total addressable market by US$2 billion to US$2.75 billion.
5 stocks under $5
We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
More reading
- Why Alcidion, Bubs, IGO, & Next Science shares are pushing higher
- 3 exciting small cap ASX shares to watch in FY 2021
- Extended jobkeeper: Which ASX shares to buy?
- Add these ASX small cap shares to your watchlist immediately
- 5 exciting small cap ASX shares to watch
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd, Clover Limited, and MACH7 FPO. The Motley Fool Australia has recommended Alcidion Group Ltd and MACH7 FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post 3 exciting small cap ASX shares to watch in August appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2ZZPTkZ
Leave a Reply